Search Browse Earnings

Prelude Therapeutics Inc — SlamSEC

Prelude Therapeutics Inc

Nasdaq:PRLD

Pharmaceutical Preparations·WILMINGTON, DE

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$7.0M

FY 2024

Adj. EBITDA

-$131.1M

-1873.0% margin

FY 2024

Net Income

-$121.8M

-1740.5% margin

FY 2024

EPS (Diluted)

-$2.02

FY 2024

Stock Price

$3.07

-5.0%

2026-03-09

52W Range

$0.61 – $4.22

P/E Ratio

-1.5x

Market Cap

$193.0M

Cash

$25.3M

FY 2024

Total Debt

—

Net Cash

$25.3M

FY 2024

Enterprise Value

$167.7M

Debt / EBITDA

0.2x

FY 2024

EV / EBITDA

-1.3x

Employees

—